.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Phillygenin (PHI), a key bioactive ligand from Forsythia suspensa, is gaining recognition for its therapeutic potential. While traditional medicine often highlights its antiviral and antioxidant properties, robust toxicological data were previously limited. A recent systematic evaluation now clarifies the Phillygenin safety profile, showing that this compound possesses a wide margin of safety for oral administration. Researchers assessed its safety through both acute and sub-chronic assays to provide essential evidence for clinical applications.
The study conducted toxicity tests following strict international guidelines to ensure reliable results. In the acute phase, KM mice received a single high dose of 5000 mg/kg body weight. Consequently, researchers observed no treatment-related mortality or toxic manifestations over 14 days, indicating a lethal dose (LD50) exceeding 5000 mg/kg. Furthermore, a 28-day sub-chronic study evaluated doses reaching 25,000 mg/kg in SD mice. Across all groups, clinical signs, body weight, and biochemical parameters remained normal. Additionally, histopathological examinations revealed no damage to vital organs.
Beyond its safety, Phillygenin significantly improves liver health by boosting essential antioxidant defenses. The research demonstrated that PHI increases levels of Superoxide Dismutase (SOD) and Glutathione (GSH) in the liver. Simultaneously, it reduces Malondialdehyde (MDA), which is a common marker of oxidative stress. Moreover, Phillygenin suppressed the expression of Pregnane X Receptor (PXR) and the enzyme CYP3A1. This finding suggests that the compound can effectively modulate xenobiotic metabolism. Collectively, these results support the development of PHI as a safe agent for hepatoprotective and antiviral therapies.
Phillygenin is a natural bioactive ligand extracted from the plant Forsythia suspensa, widely used for its antioxidant and antiviral properties.
Yes, recent toxicological studies show a high safety margin with an LD50 exceeding 5000 mg/kg and no adverse effects during long-term sub-chronic administration.
It enhances the liver\'s antioxidant capacity by increasing SOD and GSH levels while reducing oxidative damage and modulating drug-metabolizing enzymes.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always consult a qualified healthcare provider for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
1. Qian J et al. Toxicological and Liver Antioxidant Evaluation of Phillygenin Following Acute and Sub-Chronic Oral Administration. J Appl Toxicol. 2026 May 06. doi: 10.1002/jat.70224. PMID: 42092304.
2. Zhou Y et al. Phillygenin: A review of its pharmacology, pharmacokinetics, and safety. Phytomedicine. 2022;104:154316.
3. Guo H et al. Antiviral and anti-inflammatory activities of Phillygenin from Forsythia suspensa. J Ethnopharmacol. 2022;284:114812.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New toxicological data confirms Phillygenin's high safety margin and its ability to enhance liver antioxidant capacity and modulate xenobiotic metabolism....
2 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
